Rxsight, Inc. (RXST) fundamentals score
RxSight, Inc. is a commercial-stage medical technology company dedicated to providing high-quality customized vision to patients following cataract surgery. Its proprietary RxSight Light Adjustable Lens system (“RxSight system”) is the first and only commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery.
Ophthalmic Goods · Healthcare · Listed on NASDAQ
Overall: 4.6 out of 10, Weak long-term fundamentals
- Growth: 5.1/10
- Profitability: 2.4/10
- Financial health: 4.3/10
- Earnings quality: 8.0/10
- Valuation: 4.3/10
Scores are calculated from Rxsight, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10